Header

UZH-Logo

Maintenance Infos

Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers


Petrovsky, N; Quednow, Boris B; Ettinger, U; Schmechtig, A; Mössner, R; Collier, D A; Kühn, K U; Maier, W; Wagner, M; Kumari, V (2010). Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers. Neuropsychopharmacology, 35(7):1429-1439.

Abstract

Attentional gating deficits, commonly measured by prepulse inhibition (PPI) of the acoustic startle response (ASR), have been established as an endophenotype of schizophrenia. PPI is heritable and has been associated with polymorphisms in serotonin and dopamine system genes. PPI can be enhanced by nicotine, and therefore it has been proposed that schizophrenia patients smoke to ameliorate their early attentional deficits. The PPI-enhancing effects of nicotine in rodents are strain-dependent, suggesting a genetic contribution to PPI within the nicotinic acetylcholine receptor (nAChR) system. Recent human genetic studies also imply that tobacco dependence is affected by polymorphisms in the α3/α5 subunits of the nAChR (CHRNA3/CHRNA5) gene cluster. We therefore investigated the impact of two common CHRNA3 polymorphisms (rs1051730/rs1317286) on PPI, startle reactivity, and habituation of the ASR in two independent samples of 107 British healthy volunteers and 73 German schizophrenia patients. In both samples, PPI was influenced by both CHRNA3 polymorphisms (combined p-value 0.0027), which were strongly linked.. Moreover, CHRNA3 genotype was associated with chronicity, treatment, and negative symptoms in the schizophrenia sample. These results suggest that sensorimotor gating is influenced by variations of the CHRNA3 gene, which might also have an impact on the course and severity of schizophrenia.

Abstract

Attentional gating deficits, commonly measured by prepulse inhibition (PPI) of the acoustic startle response (ASR), have been established as an endophenotype of schizophrenia. PPI is heritable and has been associated with polymorphisms in serotonin and dopamine system genes. PPI can be enhanced by nicotine, and therefore it has been proposed that schizophrenia patients smoke to ameliorate their early attentional deficits. The PPI-enhancing effects of nicotine in rodents are strain-dependent, suggesting a genetic contribution to PPI within the nicotinic acetylcholine receptor (nAChR) system. Recent human genetic studies also imply that tobacco dependence is affected by polymorphisms in the α3/α5 subunits of the nAChR (CHRNA3/CHRNA5) gene cluster. We therefore investigated the impact of two common CHRNA3 polymorphisms (rs1051730/rs1317286) on PPI, startle reactivity, and habituation of the ASR in two independent samples of 107 British healthy volunteers and 73 German schizophrenia patients. In both samples, PPI was influenced by both CHRNA3 polymorphisms (combined p-value 0.0027), which were strongly linked.. Moreover, CHRNA3 genotype was associated with chronicity, treatment, and negative symptoms in the schizophrenia sample. These results suggest that sensorimotor gating is influenced by variations of the CHRNA3 gene, which might also have an impact on the course and severity of schizophrenia.

Statistics

Citations

34 citations in Web of Science®
41 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

116 downloads since deposited on 24 Jan 2011
18 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Psychiatric University Hospital Zurich > Clinic for Psychiatry, Psychotherapy, and Psychosomatics
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2010
Deposited On:24 Jan 2011 17:25
Last Modified:22 Sep 2017 13:28
Publisher:Nature Publishing Group
ISSN:0006-3223
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.1038/npp.2010.12
PubMed ID:20393456

Download

Download PDF  'Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers'.
Preview
Content: Accepted Version
Filetype: PDF
Size: 1MB
View at publisher